【摘 要】
：
Macular hole repair is a routine surgery for vitro-retinal surgeon nowadays.In general, the successful rate of hole closure was more than 90％ after vitrectomy and ILM peeling.However,less than 10％ of
【机 构】
：
Department of ophthalmology,Chang Gung Memorial Hospital,Taiwan,China
【出 处】
：
中国眼底病论坛暨第十五届全国眼底病学术会议
论文部分内容阅读
Macular hole repair is a routine surgery for vitro-retinal surgeon nowadays.In general, the successful rate of hole closure was more than 90％ after vitrectomy and ILM peeling.However,less than 10％ of macular hole could not close even with extensive ILM peeling and multiple surgeries.The vision of unclosed hole will remain poor and eventually became legal blindness.Therefore, it is vital for the vision to get anatomical success.In this talk, we will present our recent study about the gas-fluid exchange (GFE) for unclosed holes after primary vitrectomy.The GFE could further close about 60％ of the unclosed hole and improved visual acuity.The other unclosed hole after GFE may use invasive surgeries will be also discussed.
其他文献
目的 探讨抗血管内皮生长因子(VEGF)辅助的23G玻璃体切割联合超声乳化及人工晶状体植入手术对严重增生性糖尿病视网膜病变(PDR)合并白内障患者术后新生血管青光眼的作用.方法 回顾性病例对照研究.PDR合并白内障37例40只眼,分A组17例19只眼,B组20例21只眼,A组实施术前玻璃体腔抗VEGF辅助的23G玻璃体切割联合超声乳化及人工晶状体植入手术;B组实施单纯23G玻璃体切割联合超声乳化及
目的 探讨抗血管内皮生长因子(VEGF)单克隆抗体ranibizumab(商品名Lucentis)联合577波长激光光凝或玻璃体手术在治疗增生型糖尿病视网膜病变(PDR)新生血管、糖尿病黄斑水肿(DME)、视网膜静脉阻塞(RVO)包括视网膜中央静脉阻塞(CRVO)和视网膜分枝静脉阻塞(BRVO)黄斑水肿(ME)、视网膜血管炎(Eales病)、黄斑旁毛细血管扩张症(PT)、Coats病等视网膜血管疾
抗血管内皮生长因子(VEGF)单克隆抗体雷珠单抗(Lucentis)治疗视网膜中央静脉阻塞性(CRVO)黄斑水肿已被美国FDA批准.大规模大样本的临床试验证实,早期(3个月)应用可以获得更好的视力改善.在各种抗VEGF治疗的并发症中,缺血性视网膜病变,如非缺血型转变为缺血型CRVO甚至视网膜动脉阻塞等严重并发症在临床中被越来越多的报告.
目的 评估玻璃体腔注射bevacizumab治疗Coats病的治疗效果.方法 对伴有部分或全渗出性视网膜脱离的8例儿童Coats病患者和5例成人Coats病患者进行回顾性分析.患者采取玻璃体腔注射bevacizumab治疗,检测手术前以及手术后的最佳矫正视力(BCVA)、眼压、荧光素眼底血管造影、眼底相、眼部超声以及光相干断层扫描(OCT)以评价治疗效果.
Objective To determine whether the volume of retinal tissue passing between the inner and outer retina in macular edema could be used as an indicator of visual acuity.Methods Diabetic and uveitic pati
黄斑部病变是中老年人失明的主要原因,所以早期黄斑部的功能检测也就愈显重要.在黄斑部的评估上,往往眼底构造上的变化,与病患视力下降的变化,并不一定会有临床上有意义的关联,所以视力的改变就不足以代表黄斑部的整体性完整度的变化,这时除了视力以外的视觉功能评估就显得重要,但是黄斑部视觉功能评估往往是病患主观精神心理方面的检查,很难代表有意义可靠的结果.
2011年北京眼病研究是针对50岁以上人群的流行病学调查,包括来自北京北部地区3个自然村及5个社区的3468名参与者,年龄50～93岁,平均年龄(64.6±9.8)岁.加强深度扫描模式-光相干断层扫描(EDI-OCT)用于测量脉络膜厚度.其结果显示黄斑中心凹平均脉络膜厚度为(254±107) μm,与年龄(每增长1岁下降μm)及近视(每屈光度下降15 μm)呈负相关;与男性、前房深度,晶状体厚度呈
BEST病是一种少见的常染色体显性遗传性黄斑疾病,根据病程进展分为5期.临床上遇到的非典型性BEST病患者经常被误诊,甚至给予错误的治疗.我们随访了一组典型性及非典型性的BEST病患者,对其眼底表现、FFA、SD-OCT形态及电生理结果进行了分析,对BEST病的不同临床分期的SD-OCT的特异表现进行研究,探讨其病情演变,加深对该病的认识,提高确诊率,避免误诊及漏诊.
Purpose To report the visual and clinical outcomes of subthreshold diode micropulse (SDM) laser photocoagulation for chronic idiopathic central serous chorioretinopathy (ICSC) with juxtafoveal leakage
Globally, diabetic retinopathy (DR) is the leading cause of blindness among working adult people, affecting more than 100 million people.Over the past decade, there have been major developments in the